Global /United States /Healthcare /Drug Manufacturers - General /LFCR
chevron_leftBack
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc.

LFCR
NASDAQ: LFCR Delayed
4.92USD -4%
As of 13 June 2026, Lifecore Biomedical, Inc. has a market cap of $184.2M USD, ranking #21610 globally and #3503 in the United States. It ranks #1935 in the Healthcare sector, and #698 in the Drug Manufacturers - General industry.
Global Rank
21610
Country Rank
3503
Sector Rank
1935
Industry Rank
698
Key Stats
Market Cap
$184.2MUSD
Enterprise Value
$311.21MUSD
Revenue (TTM)
$129.46MUSD
EBITDA (TTM)
$8.24MUSD
Net Income (TTM)
-$34.5MUSD
EBITDA Margin
6.4%
Profit Margin
-24%
PS Ratio
1.4
PB Ratio
5.4
EV/EBITDA
37.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Paul Josephs open_in_new
Employees
382
Founded
1986
Website
lifecore.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-4% -6% 34% -43% -29% -24%

News

Loading...

LFCR Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
LFCR
Lifecore Biomedical Inc
ISIN: US5147661046
Shares Out.:
37.509M1 Shares Float: 33.79M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
4.92 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
413K%
38.1
JNJ
$547.28B
297K%
26.4
ABBV
$360.63B
196K%
97.4
MRK
$274.03B
149K%
15.1
PFE
$149.38B
81K%
19.5
$117.58B
64K%
16.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$321.52B
256.25B CHF
174K%
19.9
AZN
$288.84B
215.59B GBP
157K%
27.6
NOVN
$274.65B
218.9B CHF
149K%
20.5
NOVO-B
$181.82B
1.18T DKK
99K%
11.5
SAN
$110.1B
95.26B EUR
60K%
19.9
GSK
$108.46B
80.96B GBP
59K%
14.6
chevron_leftBack